NCT06711874

Brief Summary

This study aims to investigate the impacts of abnormally elevated PTH levels on clinical outcomes among critically ill patients with vitamin D depletion.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
320

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 21, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 24, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 2, 2024

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

December 2, 2024

Status Verified

May 1, 2024

Enrollment Period

7 months

First QC Date

November 24, 2024

Last Update Submit

November 27, 2024

Conditions

Keywords

parathyroid hormonevitamin D depletion25(OH)Dcritical illnessmortality

Outcome Measures

Primary Outcomes (1)

  • Mortality

    Survival on day 28, survival to hospital discharge

    From enrollment to day 90

Secondary Outcomes (4)

  • Acute Physiology and Chronic Health Evaluation II (APACHE II) score

    From enrollment to day 90

  • Sequential Organ Failure Assessment (SOFA) score

    From enrollment to day 90

  • ICU length of stay

    From enrollment to day 90

  • Laboratory parameters

    From enrollment to day 90

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Critically ill patient

You may qualify if:

  • \. Critically ill patients within 48 hours of ICU admission

You may not qualify if:

  • Less than 20 years old
  • Severe malnutrition (BMI\<18kg/m2)
  • Severe anemia (hemoglobin concentration \<7g/dL)
  • Receiving high-dose vitamin D treatment (\> 3000 IU/day) within four weeks
  • Have been admitted to the ICU within three months
  • Suffering from diseases that affect vitamin D concentration, calcium metabolism or bone metabolism (for example: parathyroid disease, rickets, chirtosis, and severe cirrhosis \[Child C\])
  • Patients and family members who do not speak the native language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

MeSH Terms

Conditions

Vitamin D DeficiencyHyperparathyroidismCritical Illness

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic DiseasesParathyroid DiseasesEndocrine System DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 24, 2024

First Posted

December 2, 2024

Study Start

May 21, 2024

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

December 2, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations